GLP‐1 RAs have been shown to reduce insulin resistance, which is strongly associated with the development and progression of NAFLD 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 (Figure 2). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.